Journal of the Korean Society of Food Science and Nutrition (한국식품영양과학회지)

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Antihyperglycemic Effects of Green Tea Extract on Alloxan-Induced Diabetic and OLETF Rats

Alloxan 당뇨쥐(제1형 당뇨병 모델)와 OLETF 쥐(제2형 당뇨병 모델)에서 녹차 추출물의 고혈당 억제 효과

  • Lee, Byoung-Rai (Dept. of Biochemistry, College of Medicine, Chosun University) ;
  • Koh, Ki-Oh (Dept. of Biochemistry, College of Medicine, Chosun University) ;
  • Park, Pyoung-Sim (Dept. of Hotel Culinary Arts and Nutrition, Dongkang College)
  • 이병래 (조선대학교 의과대학 생화학교실) ;
  • 고기오 (조선대학교 의과대학 생화학교실) ;
  • 박평심 (동강대학 호텔조리영양과)
  • Published : 2007.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

This study was performed to investigate the antihyperglycemic effect of green tea extracts (GTE) in diabetic rats. Experimental animals used were alloxan-induced diabetic Sprague-Dawley (SD) rats; as a model of type 1 diabetes mellitus and Otsuka Long Evans Tokushima fatty (OLETF) rats, and as a model of type 2 diabetes mellitus. Animals were randomly assigned either to continue the ad libitum diet or begin a green tea extracts (GTE) contained diet. GTE extracted from green tea was supplemented in the diet (2%). Body weight, food intake, and blood glucose concentration were recorded for 4 weeks. Animals were killed and glucose, triglyceride, and asparate aminotransferase (AST) were analysed in blood. Food intake was not affected by GTE in both alloxan.induced diabetic and OLETF rats but body weight was slightly decreased by GTE in OLETF rats. The blood glucose concentration was markedly decreased by GTE supplementation in both alloxan-induced diabetic and OLETF rats; however, triglyceride and AST levels in serum of GTE treated animals were not changed. This study shows that GTE beneficially modulate blood glucose concentration in diabetic animals. Dietary supplementation with GTE could potentially contribute to nutritional strategies for the treatment of diabetes mellitus.

녹차 추출물이 당뇨병의 고혈당에 미치는 영향을 알아보기 위하여 1형 당뇨병 모델인 alloxan 당뇨쥐와 2형 당뇨병모델인 OLETF 쥐에 녹차 추출물을 4주간 투여하면서 혈당을 측정하여 관찰하였다. 녹차 추출물 투여 후 1주, 2주, 3주 및 4주째에 꼬리 정맥에서 혈당을 측정한 결과 alloxan 당뇨쥐는 대조군에 비하여 각각 혈당이 161, 176, 177 및 181 mg/dL가 감소되었고, OLETF 쥐는 녹차 추출물 투여군이 대조군에 비하여 각각 28, 33, 38 및 28 mg/dL가 감소되어, 녹차 추출물 투여로 1형 당뇨병인 alloxan 당뇨쥐와 2형 당뇨병인 OLETF 쥐에서 모두 투여 1주일째부터 혈당의 증가 둔화가 나타나서 4주째까지 지속되었다. 녹차 추출물이 당뇨쥐의 식이섭취량 및 체중에 미치는 영향을 알아보기 위하여 실험동물에 녹차 추출물을 투여한 후 1주일 간격으로 식이소모량과 체중을 4주까지 측정한 결과, 식이소모량은 alloxan당뇨쥐와 OLETF 쥐에서 모두 대조군과 녹차 추출물 투여군 사이에 변화가 없었다. 녹차 추출물 투여 당뇨쥐에서혈청 중성지질량의 변화를 관찰한 결과 alloxan 당뇨쥐와 OLETF 쥐에서 모두 녹차 추출물 투여로 중성지질량의 변화가 없었다. 녹차 추출물 투여로 인한 조직세포 손상정도를 측정하기 위하여 alloxan 당뇨쥐와 OLETF 쥐를 대조군과 녹차 추출물 투여군으로 나누어 4주간 사육한 후 혈청 AST 활성도를 측정한 결과 녹차 추출물 투여로 혈청 AST 활성도 변화는 관찰되지 않았다. 이상의 실험 결과로 녹차 추출물을 당뇨병 쥐에 경구투여하면 혈당증가 억제효과가 나타나는데, 녹차 추출물의 혈당증가 억제효과는 1형이나 2형당뇨병 등 당뇨병의 형태와 상관없이 작용할 수 있는 것으로생각된다. 따라서 녹차 추출물은 당뇨병 치료를 위한 우수한 식사요법 보조제로 개발될 수 있을 것으로 기대된다. 또한 녹차 추출물에 함유된 혈당강하작용 물질의 검색과 작용 기전, 특성에 대한 연구가 계속된다면 우수한 혈당강하작용을 가진 물질이 개발될 수 있을 것으로 추측된다.

Keywords

References

  1. Rhee SY, Kim YS, Oh S, Choi WH, Park JE, Jeong WJ. 2005. Diabcare Asia 2001-Korea country report on outcome data and analysis. Korean J Intern Med 20: 48-54 https://doi.org/10.3904/kjim.2005.20.1.48
  2. Schwarz PE. 2005. Report from the Congress of the American Diabetes Association (ADA). Exp Clin Endocrinol Diabetes 113: 475-479 https://doi.org/10.1055/s-2005-865942
  3. Kim SM, Lee JS, Lee J, Na JK, Han JH, Yoon DK, Baik SH, Choi DS, Choi KM. 2006. Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey 2001. Diabetes Care 29: 226-231 https://doi.org/10.2337/diacare.29.02.06.dc05-0481
  4. Kim JY, Park JY, Lee KU. 1994. Diabetes and traditional medicine effect of several traditional drug on the plasma glucose levels in streptozotocin-induced diabetic rat. J Korean Diabetes Assoc 18: 377-380
  5. Sakurai T, Tsuchiya S. 1988. Superoxide production from nonenzymatically glycated protein. FEBS Lett 236: 406-410 https://doi.org/10.1016/0014-5793(88)80066-8
  6. Mullarkey CJ, Edelstein D, Brownlee M. 1990. Free radical generation by early glycation prodeucts: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173: 932-939 https://doi.org/10.1016/S0006-291X(05)80875-7
  7. Kim YS, Jung YH, Chun SS, Kim MN. 1988. The kinetics of non-enzymatic reaction in green tea during storage at different water activities and temperature. J Korean Soc Food Nutr 17: 226-232
  8. Krentz AJ, Bailey CJ. 2005. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 65: 385-411 https://doi.org/10.2165/00003495-200565030-00005
  9. Corns CM. 2003. Herbal remedies and clinical biochemistry. Ann Clin Biochem 40: 489-507 https://doi.org/10.1258/000456303322326407
  10. Tapsell LC, Hemphill I, Cobiac L, Patch CS, Sullivan DR, Fenech M, Roodenrys S, Keogh JB, Clifton PM, Williams PG, Fazio VA, Inge KE. 2006. Health benefits of herbs and spices: the past, the present, the future. Med J Aust 185: S4-24
  11. Rosen P, Osmers A. 2006. Oxidative stress in young Zucker rats with impaired glucose tolerance is diminished by acarbose. Horm Metab Res 38: 575-586 https://doi.org/10.1055/s-2006-950397
  12. Azuma K, Toyofuku Y, Iesaki T, Otsuka A, Tanaka A, Mita T, Hirose T, Tanaka Y, Daida H, Kawamori R, Watada H. 2006. Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation. Biochem Biophys Res Commun 345: 688-693 https://doi.org/10.1016/j.bbrc.2006.04.090
  13. Cabrera C, Artacho R, Gimenez R. 2006. Beneficial effects of green tea: a review. J Am Coll Nutr 25: 79-99 https://doi.org/10.1080/07315724.2006.10719518
  14. Alschuler L. 1998. Green tea: healing tonic. Am J Natur Med 5: 28-31
  15. Ko YS, Lee IS. 1985. Quantitative analysis of free amino acids and free sugars in steamed and roasted green tea by HPLC. J Korean Soc Food Nutr 14: 301-304
  16. Ahmad N, Feyes DK, Nieminen AL, Aqarwal R, Mukhtar H. 1997. Green tea constituent epigallocatechin 3 gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 89: 1881-1886 https://doi.org/10.1093/jnci/89.24.1881
  17. Dullo AG, Duret C, Rohrer D. 1999. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation and fat oxidation in humans. Am J Clin Nutr 70: 1040-1045 https://doi.org/10.1093/ajcn/70.6.1040
  18. Watanabe J, Kawabata J, Niki R. 1998. Isoiation and identification of acetyl-CoA carboxylase inhibitors from green tea (Camellia sinensis). Biosci Biotechnol Biochem 62: 529-534 https://doi.org/10.1271/bbb.62.532
  19. Beltz LA, Bayer DK, Moss AL, Simet IM. 2006. Mechanisms of cancer prevention by green and black tea polyphenols. Anticancer Agents Med Chem 6: 389-406 https://doi.org/10.2174/187152006778226468
  20. Mandel SA, Avramovich-Tirosh Y, Reznichenko L, Zheng H, Weinreb O, Amit T, Youdim MB. 2005. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway. Neurosignals 14: 46-60 https://doi.org/10.1159/000085385
  21. Arimoto-Kobayashi S, Inada N, Sato Y, Sugiyama C, Okamoto K, Hayatsu H, Negishi T. 2003. Inhibitory effects of (-)-epigallocatechin gallate on the mutation, DNA strand cleavage, and DNA adduct formation by heterocyclic amines. J Agric Food Chem 51: 5150-5153 https://doi.org/10.1021/jf0302761
  22. Shirai T, Reshad K, Yoshitomi A, Chida K, Nakamura H, Taniguchi M. 2003. Green tea-induced asthma: relationship between immunological reactivity, specific and non-specific bronchial responsiveness. Clin Exp Allergy 33: 1252-1255 https://doi.org/10.1046/j.1365-2222.2003.01744.x
  23. Wolfram S, Raederstorff D, Preller M, Wang Y, Teixeira SR, Riegger C, Weber P. 2006. Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr 136: 2512-2518
  24. Hosoda K, Wang MF, Liao ML, Chuang CK, Iha M, Clevidence B, Yamamoto S. 2003. Antihyperglycemic effect of oolong tea in type 2 diabetes. Diabetes Care 26: 1714-1718 https://doi.org/10.2337/diacare.26.6.1714
  25. Yamabe N, Yokozawa T, Oya T, Kim M. 2006. Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats. J Pharmacol Exp Ther 319: 228-236 https://doi.org/10.1124/jpet.106.107029
  26. Ryu OH, Lee J, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. 2006. Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract 71: 356-358 https://doi.org/10.1016/j.diabres.2005.08.001
  27. Vega P, Gaule C, Mancilla J, Del Villar E. 1993. Comparison of alloxan and streptozotocin induced diabetes in rats: differential effects on microsomal drug metabolism. Gen Pharmacol 24: 489-495 https://doi.org/10.1016/0306-3623(93)90336-V
  28. Kawano K, Hirashima T, Mori S, Natori T. 1994. OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Res Clin Pract 24: S317-S320 https://doi.org/10.1016/0168-8227(94)90269-0
  29. Janle EM, Portocarrero C, Zhu Y, Zhou Q. 2005. Effect of long-term oral administration of green tea extract on weight gain and glucose tolerance in Zucker diabetic (ZDF) rats. J Herb Pharmacother 5: 55-65 https://doi.org/10.1300/J157v05n03_06
  30. Diepvens K, Kovacs EM, Nijs IM, Vogels N, Westerterp- Plantenga MS. 2005. Effect of green tea on resting energy expenditure and substrate oxidation during weight loss in overweight females. Br J Nutr 94: 1026-1034 https://doi.org/10.1079/BJN20051580
  31. Rabinovitch A. 1998. Animal models of type 1 diabetes are relevant to human IDDM. Diabetes Metab Rev 14: 189-190 https://doi.org/10.1002/(SICI)1099-0895(199806)14:2<189::AID-DMR3210>3.0.CO;2-Y
  32. Scott FW, Cloutier HE, Kleemann R, Woerz-Pagenstert U, Rowsell P, Modler HW, Kolb H. 1997. Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats: dose, timing, early effect on islet area, and switch in infiltrate from Th1 to Th2 cells. Diabetes 46: 589-598 https://doi.org/10.2337/diabetes.46.4.589
  33. Wada R, Koyama M, Mizukami H, Odaka H, Ikeda H, Yagihashi S. 1999. Effects of long-term treatment with alpha-glucosidase inhibitor on the peripheral nerve function and structure in Goto-Kakizaki rats: a genetic model for type 2 diabetes. Diabetes Metab Res Rev 15: 332-337 https://doi.org/10.1002/(SICI)1520-7560(199909/10)15:5<332::AID-DMRR55>3.0.CO;2-L
  34. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. 1992. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41: 1422-1428 https://doi.org/10.2337/diabetes.41.11.1422
  35. Brunzell JD, Ayyobi AF. 2003. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med 115: 24S-28S https://doi.org/10.1016/j.amjmed.2003.08.011
  36. Krauss RM. 2004. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 27: 1496-1504 https://doi.org/10.2337/diacare.27.6.1496

Cited by

  1. Anti-diabetic Effects of Fermented Green Tea in KK-AyDiabetic Mice vol.45, pp.4, 2013, https://doi.org/10.9721/KJFST.2013.45.4.488
  2. Four months of magnetized water supplementation improves glycemic control, antioxidant status, and cellualr DNA damage in db/db mice vol.49, pp.6, 2016, https://doi.org/10.4163/jnh.2016.49.6.401
  3. 제2형 당뇨 마우스에서 십조탕(十棗湯)에 의한 혈당 및 신기능 부전 개선효과 vol.32, pp.1, 2017, https://doi.org/10.6116/kjh.2017.32.1.15.